Quantum Genomics SA
Research Quantum Genomics SA (ALQGC) on Bullrun: market cap EUR 5.02M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALQGC
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 5.02M
- Financial periodFY2024
- RevenueEUR 0
- Revenue growth-100.0%
- Net income-EUR 8.89M
Valuation Snapshot
latest market cap is EUR 5.02M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2024 | EUR 0 | -EUR 8.89M | n/a | n/a | -0.09 | EUR 301.02K | EUR 2.64M | -EUR 2.46M |
| FY2023 | EUR 10.06K | -EUR 3.17M | n/a | -14205.0% | -0.13 | EUR 3.55M | EUR 2.72M | EUR 436.66K |
| FY2022 | EUR 604.98K | -EUR 24.94M | -EUR 20.21M | -4776.6% | -0.72 | EUR 10.40M | EUR 3.03M | EUR 3.61M |
| FY2021 | EUR 116.21K | -EUR 16.56M | n/a | -15781.1% | -0.61 | EUR 8.54M | EUR 3.00M | EUR 11.43M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 5.02M | n/a | n/a | n/a |
About Quantum Genomics SA
Quantum Genomics Société Anonyme is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Quantum Genomics SA's market cap?
Quantum Genomics SA's market capitalization is EUR 5.02M.
What does Quantum Genomics SA do?
Quantum Genomics Société Anonyme is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.